CRON vs HITI vs VREOF Stock Comparison

Cronos, High Tide and Vireo Growth Prices as of Oct 28, 2026 Peers: Industry group
CRON Cronos Group Inc.
$3.35 -1.8% 1M +34.5% 1Y
Market cap
$1.24B
P/E
17.9x
Revenue (TTM)
$236.78M
Div. yield
–
Cannabis Consumer Staples
7 wins
HITI High Tide Inc.
$2.69 -4.3% 1M -14.9% 1Y
Market cap
$234.66M
P/E
–
Revenue (TTM)
$520.13M
Div. yield
–
Cannabis Consumer Staples
1 win
VREOF Vireo Growth Inc.
$7.77 -27.2% 1M -58.4% 1Y
Market cap
$350.00M
P/E
–
Revenue (TTM)
$511.67M
Div. yield
–
Cannabis Consumer Staples
1 win

Head to Head

9 decided of 12

Cronos leads on 7 of the 12 questions below (Cronos 7, Vireo Growth 1, High Tide 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCRONHITIVREOFLeader
Larger companyMarket capitalisation $1.24B $234.66M $350.00M CRON
Cheaper on earningsLower P/E, profitable companies only 17.9x -9.3x -5.2x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 20.9x 26.9x — CRON
Faster revenue growthRevenue growth, trailing twelve months +36.1% +31.0% +316.7% VREOF
More profitableNet margin, trailing twelve months 29.6% -4.5% -13.1% CRON
Better return on capitalReturn on invested capital — -1.5% — –
Less leveragedLower net debt / EBITDA — -0.7x 4.7x HITI
Higher dividend yieldTrailing dividend yield — — — –
Better 1-year returnPrice return, last 12 months +34.5% -14.9% -58.4% CRON
Better 5-year returnAnnualised price return, 5 years -8.4%/yr -13.2%/yr -29.5%/yr CRON
Less volatileAnnualised volatility, 1 year 39.4% 41.7% 76.0% CRON
Higher overall scoreMean of the five percentile scores vs peers 88/100 66/100 51/100 CRON

Percentile Scorecard

CRONHITIVREOF

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCRONHITIVREOF
Valuation 70 #12 of 38 73 #11 of 38 49 #20 of 38
Growth 100 #1 of 35 59 #15 of 35 53 #17 of 35
Profitability 77 #9 of 36 63 #14 of 36 57 #16 of 36
Financial Health 100 #1 of 39 68 #13 of 39 45 #22 of 39
Shareholder Returns 92 #2 of 13 – –
Overall 88 66 51
  • CRON ranked among 40 companies in Tobacco and Cannabis
  • HITI ranked among 40 companies in Tobacco and Cannabis
  • VREOF ranked among 40 companies in Tobacco and Cannabis

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCRONHITIVREOFSPY
1 month -1.8%-4.3%-27.2% +0.9%
3 months +17.1%+31.2%-17.7% +5.9%
6 months +29.8%+12.1%-39.4% +8.5%
Year to date +27.4%+1.5%-57.7% +13.3%
1 year +34.5%-14.9%-58.4% +12.4%
3 years +94.8%+100.7%+36.3% +88.1%
3 years, per year +24.9%+26.2%+10.9% +23.5%
5 years -35.5%-50.7%-82.6% +68.2%
5 years, per year -8.4%-13.2%-29.5% +11.0%

Risk

MeasureCRONHITIVREOFSPY
Volatility, 1Y 39.4%41.7%76.0% 12.7%
Downside volatility, 1Y 35.9%40.9%71.3% 12.7%
Beta vs S&P 500, 1Y 0.600.931.15 1.00
Return / volatility, 1Y 0.88-0.36-0.77 0.98
Max drawdown, 5Y -75.9%-86.8%-96.1% -25.4%
From 52-week high -5.6%-14.9%-61.5% -0.9%
52-week high $3.55$3.16$20.19 $779.14
52-week low $2.30$2.05$7.77 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCRONHITIVREOF
P/E now vs peer median 17.9xmedian 16.6x -9.3xmedian 16.6x -5.2xmedian 16.6x
P/S now vs peer median 5.2xmedian 0.9x 0.5xmedian 0.9x 0.7xmedian 0.9x
EV/EBITDA now vs peer median 37.5xmedian 12.9x 26.1xmedian 12.9x 13.9xmedian 12.9x
P/FCF now vs peer median 24.9xmedian 23.3x 25.7xmedian 23.3x -3.0xmedian 23.3x
P/B now vs peer median 1.1xmedian 1.0x 2.7xmedian 1.0x 0.8xmedian 1.0x
PEG now vs peer median 0.50median 0.57 -0.45median 0.57 0.07median 0.57

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCRONHITIVREOF
Revenue $236.78M $520.13M $511.67M
Gross profit $82.13M $135.79M $248.87M
Operating income -$2.43M -$1.43M $1.69M
Net income $77.88M -$23.71M -$67.11M
Free cash flow $49.82M $9.13M -$116.31M
R&D $5.36M – –
EPS (diluted) $0.19 $-0.56 $-1.49
Cash & equivalents $467.02M $27.13M $122.70M
Total debt – $78.40M $300.10M
Shares (diluted) 375.06M 42.43M 45.09M
Enterprise value -$1.98B $135.90M -$154.55M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCRONHITIVREOF
P/E 17.9x -9.3x -5.2x
P/FCF 24.9x 25.7x -3.0x
P/Operating cash flow 20.7x 13.2x 13.4x
P/S 5.2x 0.5x 0.7x
P/B 1.1x 2.7x 0.8x
P/Tangible book 1.1x 2.7x 1.6x
EV/EBITDA 37.5x 26.1x 13.9x
EV/EBIT -183.2x -159.9x 310.6x
EV/Revenue 1.9x 0.4x 1.0x
EV/FCF 8.9x 25.0x -4.5x
EV/Operating cash flow 7.4x 12.8x 20.1x
PEG (3Y EPS CAGR) 0.50 -0.45 0.07

Growth

14 metrics
MetricCRONHITIVREOF
Revenue growth (1Y) 36.1% 31.0% 316.7%
Revenue CAGR (3Y) 30.1% 14.2% 87.9%
Gross profit growth (1Y) 92.5% 29.0% 330.7%
Gross profit CAGR (3Y) 98.9% 12.5% 88.9%
Operating income growth (1Y) 95.5% -205.7% -43.7%
Operating income CAGR (3Y) 70.6% 68.6% 132.3%
Net income growth (1Y) 264.6% -252.5% -59.7%
Net income CAGR (3Y) 36.5% 19.8% -21.5%
EPS growth (1Y) 288.8% -243.6% -1,879%
EPS CAGR (3Y) 35.6% 20.7% -72.0%
Operating cash flow growth (1Y) 199.9% – 252.1%
Operating cash flow CAGR (3Y) 37.8% – 65.4%
Free cash flow growth (1Y) 651.8% 21.7% -292.4%
Free cash flow CAGR (3Y) 35.7% 169.3% -100.1%

Profitability

14 metrics
MetricCRONHITIVREOF
Gross margin 34.7% 26.1% 48.6%
EBITDA margin 5.0% 1.7% 7.4%
Operating margin -1.0% -0.3% 0.3%
Pretax margin 28.9% 3.5% -2.9%
Net margin 29.6% -4.5% -13.1%
FCF margin 21.0% 1.8% -22.7%
Operating cash flow margin 25.4% 3.4% 5.1%
Return on equity 7.1% -29.9% -4.1%
Return on assets 6.7% -9.3% -1.4%
Return on invested capital – -1.5% –
Return on capital employed -0.2% -0.8% 0.2%
Asset turnover 0.2x 2.0x 0.5x
Cash conversion (OCF / net income) 0.8x -0.7x -0.4x
Stock comp / revenue 2.7% – 4.3%

Financial Health

11 metrics
MetricCRONHITIVREOF
Debt / assets – 7.9% 23.6%
Debt / equity – 0.2x 0.7x
Net debt / EBITDA – -0.7x 4.7x
Debt / FCF – 2.3x -2.6x
Liabilities / assets 5.3% 67.5% 65.3%
Equity / assets 94.7% 32.5% 34.7%
Interest coverage – -0.3x 0.1x
Current ratio 16.2x 1.5x 1.0x
Quick ratio 14.8x 0.5x 0.3x
Cash ratio 14.1x 0.4x 0.3x
Altman Z-score 13.59 1.96 0.31

Shareholder Returns

7 metrics
MetricCRONHITIVREOF
Dividend yield – – –
Net buyback yield 3.1% – –
Shareholder yield 3.1% – –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCRONHITIVREOF
Forward P/E 20.9xFY2026 26.9xFY2026 –
EPS, next fiscal year $0.16FY2026 $0.10FY2026 $-0.07FY2026
EPS growth, the year after +18.8% +10.0% –
Revenue, next fiscal year $206.33MFY2026 $561.45MFY2026 $728.10MFY2026
Revenue growth, next FY +40.7%FY2026 +32.5%FY2026 +170.9%FY2026
Revenue growth, the year after +26.5% +12.5% +63.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCRONHITIVREOF
Held by institutions 12.8% 8.1% –
Institutions holding 195 47 –
Change in shares held, QoQ -2.5% -15.1% –
Institutions buying 71 20 –
Institutions selling 41 15 –
Buyers to sellers 1.73 1.33 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CRONHITIVREOF
CRON 1.00 0.45 0.36
HITI 0.45 1.00 0.29
VREOF 0.36 0.29 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CRON, HITI and VREOF?

Cronos (CRON) is the largest by market capitalisation: Cronos (CRON) $1.24B, High Tide (HITI) $234.66M, Vireo Growth (VREOF) $350.00M.

Which company is growing faster?

Vireo Growth (VREOF) grew revenue fastest over the trailing twelve months: Cronos (CRON) +36.1%, High Tide (HITI) +31.0%, Vireo Growth (VREOF) +316.7%.

Which company is more profitable?

Cronos (CRON) has the highest net margin (Cronos (CRON) 29.6%, High Tide (HITI) -4.5%, Vireo Growth (VREOF) -13.1%).

Which stock has performed better?

Over the past year Cronos (CRON) returned the most: Cronos (CRON) +34.5%, High Tide (HITI) -14.9%, Vireo Growth (VREOF) -58.4%. Over five years, Cronos (CRON) compounded fastest (Cronos (CRON) -8.4%/yr, High Tide (HITI) -13.2%/yr, Vireo Growth (VREOF) -29.5%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Cronos (CRON) has been the steadiest (Cronos (CRON) 39.4%, High Tide (HITI) 41.7%, Vireo Growth (VREOF) 76.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CRON, HITI and VREOF?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cronos (CRON) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.